Get the Stockscreener App
9.74
2.60%
-0.26
After Hours:
9.93
0.19
+1.95%
Exagen Inc stock is traded at $9.74, with a volume of 141.14K.
It is down -2.60% in the last 24 hours and up +1.88% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$10.00
Open:
$10.04
24h Volume:
141.14K
Relative Volume:
0.51
Market Cap:
$214.32M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-10.36
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+0.72%
1M Performance:
+1.88%
6M Performance:
+192.49%
1Y Performance:
+223.59%
1-Day Range:
$9.70
$10.09
1-Week Range:
$9.55
$10.28
52-Week Range:
$2.38
$10.34
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
9.74 | 211.90M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Exagen (NASDAQ:XGN) Upgraded at B. Riley - Defense World
Tools to monitor Exagen Inc. recovery probability2025 Stock Rankings & Safe Entry Trade Reports - Newser
Chart based exit strategy for Exagen Inc.Entry Point & Short-Term Trading Opportunity Alerts - Newser
Using data models to predict Exagen Inc. stock movementEarnings Beat & AI Enhanced Execution Alerts - Newser
What makes Exagen Inc. stock price move sharplyMarket Volume Report & Weekly High Momentum Picks - Newser
Using economic indicators to assess Exagen Inc. potentialMarket Trend Review & Precise Buy Zone Tips - Newser
Will earnings trigger a reversal in Exagen Inc.2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
Price momentum metrics for Exagen Inc. explainedJuly 2025 Summary & Low Drawdown Trading Strategies - Newser
Can technical indicators confirm Exagen Inc.’s reversalMarket Trend Summary & Accurate Trade Setup Notifications - Newser
Live market analysis of Exagen Inc.Weekly Investment Recap & Daily Stock Momentum Reports - Newser
How to forecast Exagen Inc. trends using time seriesJuly 2025 Sector Moves & Verified Swing Trading Watchlists - Newser
Intraday pattern recognizer results for Exagen Inc.July 2025 Chart Watch & Momentum Based Trading Ideas - Newser
Using AI based signals to follow Exagen Inc.July 2025 Outlook & Low Risk High Win Rate Picks - Newser
Combining machine learning predictions for Exagen Inc.Portfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Exagen Inc. (NASDAQ:XGN) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Exagen (NASDAQ:XGN) Now Covered by Analysts at B. Riley - Defense World
Tick level data insight on Exagen Inc. volatilityJuly 2025 Volume & Consistent Growth Equity Picks - Newser
Smart tools for monitoring Exagen Inc.’s price actionMarket Growth Report & Community Consensus Picks - Newser
B. Riley Initiates Exagen at Buy With $15 Price Target - MarketScreener
Exagen initiated with a Buy at B. Riley - TipRanks
Exagen Inc. (NASDAQ:XGN) Receives Average Recommendation of “Buy” from Analysts - Defense World
Published on: 2025-09-11 07:31:01 - Newser
Understanding Exagen Inc.’s price movementWeekly Trade Review & Real-Time Stock Movement Alerts - Newser
Exagen Inc. stock trend forecastGap Up & Weekly Return Optimization Plans - Newser
What recovery options are there for Exagen Inc.Treasury Yields & Fast Gaining Stock Reports - Newser
Can you recover from losses in Exagen Inc.July 2025 Market Mood & Accurate Intraday Trade Tips - Newser
Analyzing net buyer seller activity in Exagen Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Is Exagen Inc. reversing from oversold territoryGap Down & Daily Risk Controlled Trade Plans - Newser
Exagen Inc.’s volatility index tracking explainedJuly 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Top chart patterns to watch in Exagen Inc.Quarterly Profit Summary & Real-Time Buy Zone Alerts - Newser
How to use Fibonacci retracement on Exagen Inc.July 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Applying chart zones and confluence areas to Exagen Inc.Chart Signals & Safe Entry Point Alerts - Newser
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):